Key Highlights
● Brighthouse closed at $50.03 on Tuesday, October 6, up 0.42%, as the S&P 500 added 0.58% to a record close.
● The $70.00 per share Aquarian Capital buyout, valued at about $4.1 billion, still needs insurance regulatory approvals in Delaware, New York and Massachusetts.
● At $50.03, the stock sits roughly 29% below the $70 offer, and the Merger agreement's end date has extended to December 6, 2026.
● Second-quarter adjusted Earnings were $4.45 per share, and record Shield Level Annuity sales reached $2.1 billion.
Why did Brighthouse Financial (NASDAQ:BHF) stock move on Tuesday? Shares of the Charlotte, North Carolina-based annuity and life insurer rose 0.42% to close at $50.03 on October 6, 2026, recovering part of the previous session's 0.40% decline to $49.82. The gain came on a broadly positive day for US equities, when the S&P 500 added 0.58% to a record close and the Dow Jones Industrial Average rose 0.49%, according to a market recap of the session. No company-specific press release, SEC filing or analyst action dated October 6 was identified, so the modest uptick looks like ordinary trading in a stock that is now priced almost entirely around one question: whether its pending sale to Aquarian Capital will close.
The move and its catalyst
Brighthouse agreed in November 2025 to be acquired by an affiliate of Aquarian Capital for $70.00 per share in cash, a deal valued at about $4.1 billion. Common stockholders approved the merger on February 12, 2026. The remaining hurdles are insurance regulatory approvals in Delaware, New York and Massachusetts. In its second-quarter earnings release, Brighthouse said the transaction was still expected to close in 2026 and that the merger agreement's end date extends automatically to December 6, 2026, if the deal was not completed by September 6, 2026.
That extension has now been triggered. Media reports on September 10 said the Takeover was dragging as regulators dug in, and those reports said Delaware's insurance regulator had questioned Aquarian founder Rudy Sahay about capital sources, use of funds and plans for managing Brighthouse's balance sheet. The same report described Aquarian's financing as resting largely on a $3 billion backstop from Mubadala Capital, plus a $1.5 billion bank Loan and about $406 million of Brighthouse's own cash. Sahay was quoted as saying, "We are working closely with the regulators as they review our application."
In August, the Delaware Insurance Department published a statement describing its review of Aquarian's Form A application, saying it had hired outside actuaries, valuation experts, financial advisors and investigators and that a public hearing would be scheduled only once the application was deemed complete. The department said no inference should be drawn about the stage of the review. Then on September 22, media reports said that Sixth Street-backed Talcott Financial Group had renewed its interest in Brighthouse through a private letter to the board, positioning itself as a fallback if the Aquarian deal falls through. Brighthouse shares rose about 4% that day to $51.90.
The market's skepticism is visible in the price. At $50.03, the stock sits roughly $20 below the $70 offer, a discount of about 29%. Shares fell 4.04% on September 30 without a clear company announcement, and they are down about 23% year to date.
What the company does
Brighthouse Financial was spun off from MetLife (NYSE:MET) in 2017 and sells annuities and Life insurance in the United States through independent distribution partners. It reports through Annuities, Life, Run-off, and Corporate & Other segments. Its biggest growth product is the Shield Level registered index-linked annuity, which offers partial downside protection with capped market upside. The company is listed on the Nasdaq and is a constituent of the S&P MidCap 400.
Revenue-per-employee standing
Brighthouse appears on lists of US companies with the highest Revenue per employee, which reflects how lean a large insurance Balance Sheet can be. With about 1,400 employees and trailing twelve-month revenue of roughly $6.84 billion, market data puts its revenue per employee at about $4.88 million. Insurers' reported revenue includes premiums, fees, Investment income and volatile derivative gains and losses, so the figure can swing considerably from year to year.
Recent financials and valuation
For the second quarter of 2026, Brighthouse reported Net Income available to shareholders of $956 million, or $16.53 per diluted share, compared with $60 million a year earlier. Adjusted earnings, the company's non-GAAP measure, were $258 million, or $4.45 per share, up from $3.43, though below the roughly $4.77 consensus estimate cited in market coverage. Total revenues were $1.62 billion. Annuity sales reached $2.4 billion, including record Shield Level sales of $2.1 billion, and life insurance sales were $39 million. The estimated combined risk-based capital ratio was between 430% and 450%, and holding-company Liquid assets were about $0.9 billion.
Book value per share excluding accumulated other comprehensive income was $156.10 at quarter-end. Market data providers list a market Capitalization of roughly $2.9 billion, a trailing price-to-earnings ratio near 4 and a Price-to-Book Ratio of about 0.44. Those low multiples are typical of Variable Annuity writers, whose earnings swing with markets and hedging.
Sector context
Life and annuity insurers have benefited from higher interest rates, which raise investment yields and support Demand for fixed and index-linked annuities. The 10-year Treasury Yield was around 5.26% to 5.27% on October 6, according to the session recap. Private capital has been an active buyer of life and annuity balance sheets over the past several years, which helps explain why both Aquarian and Sixth Street-backed Talcott have pursued Brighthouse. Regulators, however, have become more focused on how private-capital owners fund and invest insurance assets, and that scrutiny is now central to the Brighthouse transaction.
Risks
The main risk is that regulators reject or demand major changes to the Aquarian deal, or that it cannot close by the December 6 outside date. If that happens, the stock would trade on its standalone fundamentals, and holders would be relying on a possible alternative bid that so far has only been reported. Financing could also be a risk if lenders or co-investors change terms. On the operating side, Brighthouse's earnings are exposed to Equity markets, interest rates, hedge performance and actuarial assumption reviews, all of which have caused large swings in past GAAP results.
The December 6 outside date and the Delaware review
Any word from the Delaware Insurance Department about a Form A public hearing, decisions from New York and Massachusetts regulators, and any merger agreement amendment or further extension as December 6 approaches will matter most. Any formal disclosure about the Talcott interest would also be significant. Brighthouse's third-quarter results, which last year came in early November, will update its capital ratio, Liquidity and annuity sales, along with the company's latest description of the deal timeline.






Please wait processing your request...